Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

uPAR Targeted SPECT imaging probes for detection of breast cancer

Malgorzata Lipowska, Hari Sajja and Lily Yang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1520;
Malgorzata Lipowska
1Radiology, Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hari Sajja
2Surgery, Winship Cancer Institute, Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lily Yang
2Surgery, Winship Cancer Institute, Emory University, Atlanta, GA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1520

Objectives Urokinase plasminogen activator (uPA) and its cell surface receptor (uPAR) are over-expressed in breast cancer as well as in several other human cancers and play an important role in tumor growth, metastasis and cancer prognosis. The goal of this project was to develop 99mTc labeled uPAR-targeted radiotracers as potential tumor-targeted imaging probes for non-invasive in vivo imaging of breast cancer.

Methods Two small peptides, a C-terminal His6-tagged amino terminal fragment (ATF, ~17kDa), known to be uPAR specific, and an N-terminal NTA-nine-mer peptide (AE105, 1.4 kDa), an uPAR antagonist, were radiolabeled with [99mTc(CO)3(H2O)3]+ produced via an IsoLink kit. 99mTc-ATF was purified by centrifugal ultrafiltration and its 99mTc labeling was confirmed using a 15% SDS-PAGE gel with exposure to radiographic film overnight at 4°C; 99mTc-AE105 was isolated by HPLC. Stability of both radiotracers was determined in PBS buffer pH 7.4 and with histidine challenge; in vitro uptake of 99mTc-ATF in human breast cancer cell lines, MDA-MB-231 that represent a high level of uPAR expression and T47D that has a very low or negative level of uPAR, was also measured.

Results Both radiotracers were stable at PBS buffer pH 7.4 for 24 h and no significant re-oxidation, ligand exchange or decomposition were observed even at a 1000-fold molar excess of histidine for 6 h at room temperature. 99mTc-ATF activity was detected at the 17 kDa location, which corresponds to the size of the ATF-peptide. Binding of 99mTc-ATF peptide to the uPAR positive MDA-MB-231 cancer cells was 2.6 fold higher than that binding to uPAR negative T47D cells showing that 99mTc-ATF retains specificity. In-vitro cell binding of 99mTc-AE105 needs to be assessed.

Conclusions 99mTc radiolabeling of small uPAR binding peptides provides a potentially versatile route to the development of tumor-targeting probes.

Research Support This work was supported by the NIH grant 1P50 CA128301

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
uPAR Targeted SPECT imaging probes for detection of breast cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
uPAR Targeted SPECT imaging probes for detection of breast cancer
Malgorzata Lipowska, Hari Sajja, Lily Yang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1520;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
uPAR Targeted SPECT imaging probes for detection of breast cancer
Malgorzata Lipowska, Hari Sajja, Lily Yang
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1520;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

  • 99mTc-SAMA-GGG-Ahx-BBN for GRP receptor targeting
  • In vivo evaluation of EGCG stabilized gold-198 nanoparticles in prostate cancer bearing mice
  • New Tc-carbonyl based octreotide derivatives
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Oncology

New Radiopharmaceuticals-Oncology Posters

  • New Tc-carbonyl based octreotide derivatives
  • Estimation of radioiodinated PYK as an imaging agent for assessment of EGFR-TK activity
  • Synthesis of nitroimidazole derivatives for 68Ga labeling and test as a new ligand for imaging tumor hypoxia
Show more New Radiopharmaceuticals-Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire